Suchergebnisse - "Calleja, José L."

PubPharm (63)

1

Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Villagrasa, A. | Hernández-Gea, V. | Bataller, R. | +48

2

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Nicoară-Farcău, O. | Lozano, J. | Alonso, C. | +24

3

Spleen Stiffness : The "New Kid on the Block" in the Diagnosis of Clinical Significant Portal Hypertension

enthalten in: Journal of clinical and experimental hepatology | 2023

von Llop, E. | Calleja, J.

4

Alcohol‐related liver disease phenotype impacts survival after an acute variceal bleeding episode

enthalten in: Liver International | 2023

von Villagrasa, A. | Hernández‐Gea, V. | Bataller, R. | +47

5

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Calleja, J. | Rivera-Esteban, J. | Aller, R. | +14

6

Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

enthalten in: Gastroenterologia y hepatologia | 2022

von Turnes, J. | Rincón, D. | Calleja, J. | +15

7

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

enthalten in: Liver International | 2022

von Calleja, J. | Rivera‐Esteban, J. | Aller, R. | +14

8

Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis

enthalten in: Journal of hepatology | 2021

von Villanueva, C. | Albillos, A. | Genescà, J. | +14

CommentIn: J Hepatol. 2021 Nov;75(5):1241-1242. - PMID 34107291

9

Impact of sustained viral response in the evolution of minimal hepatic encephalopathy : A prospective pilot study

enthalten in: Annals of hepatology | 2019

von Hernández-Conde, M. | Fernández-Carrillo, C. | Llop, E. | +5

10

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI) : a randomised, double-blind, placebo-controlled, multicentre trial

enthalten in: Lancet (London, England) | 2019

von Villanueva, C. | Albillos, A. | Genescà, J. | +12

CommentIn: Lancet. 2019 Apr 20;393(10181):1571-1572. - PMID 30910327

1
2
3
4
5
6
7
Nächster »
[7]